TSPO Modulation in AD

NCT07191821 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer s Disease

Interventions

DRUG: XBD173

Sponsor

Imperial College London